Uncategorized
Long-term anti-VEGF therapy maintains visual improvements
BOSTON — Long-term treat-and-extend anti-VEGF therapy maintains vision in some patients, even after 8 years and more than 50 injections, according to a study presented here“Consistent use of anti-VEGF therapy can provide long-term maintenance of vision in patients with neovascular AMD in a typical retina practice,” David Adrean, MD, said in a paper presentation at the American Society of Retina Specialists meeting.